Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease

Seiichi Hayato, Osamu Takenaka, Sree Harsha Sreerama Reddy, Ishani Savant Landry, Larisa Reyderman, Akihiko Koyama, Chad J. Swanson, Sanae Yasuda, Ziad Hussein

View at source ↗PDF ↗Article41 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1002/psp4.12862
Published
Sep 27, 2022
Venue
CPT Pharmacometrics & Systems Pharmacology
DOI
10.1002/psp4.12862
PubMed
36165093
Categories
Alzheimer's disease research and treatments
License
cc-by-nc
Provenance
openalex

Topics